UK Cialis Rx-To-OTC Switch World-First For Sanofi, H2 2023 Launch Planned
Executive Summary
The UK is the first country to allow OTC access to Sanofi's tadalafil-based erectile dysfunction drug Cialis following a successful switch. Approved as a pharmacy medicine, Sanofi will launch Cialis Together in the second half of the year. Cialis will compete against Viatris' sildenafil-based Viagra Connect in the men's sexual health and wellness category, which has seen a proliferation of products in recent months.
You may also be interested in...
Haleon Enters US OTC Erectile Dysfunction Race With Futura Deal
Haleon steps into the US OTC erectile dysfunction market with a commercialization deal for Futura's drug-free MED3000 gel, recently approved by the FDA as a de novo medical device.
ED Indication Reaches US OTC Market With FDA Approval Of UK Firm Futura’s Eroxon Gel
Approved through De Novo regulatory pathway used to classify novel medical devices for which there is no legally marketed predicate product, Eroxon, packaged in single-use tubes, gives Futura first entry to US market for OTC therapeutic products approved with ED indication.
Sanofi Launches OTC Cialis In UK
Men in the UK can now access tadalafil without a prescription with the launch of Sanofi's Cialis Together in Boots pharmacies.